Capabilities

Integrated Drug Discovery & Development

HOME

>

Capabilities

>

Integrated Drug Development Platform

An international symposium presented in collaboration with Nature Partnerships,held at Saïd Business School, University of Oxford.

Show more

We have built an integrated drug development platform connecting discovery and research, manufacturing and CMC, clinical trials and development, and our clinical network and real-world data.

Linking the specialist functions within the group with universities and research institutions in Japan and abroad, we carry research findings into the next stage of development, and turn observations from the clinic into new research hypotheses.


Contents

01

The integrated platform

03

Manufacturing and CMC


02

Discovery and research

04

Clinical development and clinical network


Contents

01

The integrated platform

02

Discovery and research

03

Manufacturing and CMC


04

Clinical development and clinical network


Integrated Structure

In drug development it matters that the findings from each stage — discovery research, manufacturing and CMC, non-clinical work, clinical development — are assessed continuously. Advalife Science Group links these specialist functions so that the evidence behind each decision carries through to the next stage.

Working from a complex-systems approach to drug discovery, we form research hypotheses from clinical observation and carry them through scientific validation, intellectual property, joint research, licensing and clinical development.

Discovery research

trending_flatarrow_downward

Non-clinical

trending_flatarrow_downward

Manufacturing and CMC

trending_flatarrow_downward

Clinical trials and development

trending_flatarrow_downward

Clinical network and real-world data

Intellectual Property

Partnering & Licensing

The five items above form the development sequence; the two below run across every stage.


Discovery & Research

With the discovery and development of new drug candidates at its centre, our work analyses individual molecules and mechanisms of action in detail while also testing the layered interactions of cells, tissue, immunity and metabolism.

Observations made in clinical practice are brought back as research hypotheses and, through joint research with universities and research institutions in Japan and abroad, taken forward into work on mechanisms of action, non-clinical evaluation and translational research.

For details of our research, our scientific platform and our collaborations, please see


Manufacturing & CMC

According to the stage a candidate has reached, we work on the manufacturing process, quality attributes, specifications, stability and formulation, turning research results into reproducible manufacturing and quality control. Drawing on the pharmaceutical function within the group, we are building a CMC foundation with clinical development and future regulatory submission in view.

PHARMACEUTICAL MANUFACTURING

NOVARK BIO Co.,Ltd

The pharmaceutical function within the group, responsible for manufacturing and CMC, process development, formulation and injectable development, and quality control.

PROCESS DEVELOPMENT

Process and formulation development

Work on the manufacturing process and on formulation proceeds according to the characteristics of each candidate and the stage it has reached.

QUALITY

Quality control

Quality attributes, specifications, testing and data integrity underpin the quality foundation that runs from research through to clinical development. Details are set out under Quality, Ethics & Governance.

PHARMACEUTICAL MANUFACTURING

NOVARK BIO株式会社

製造・CMC、プロセス開発、製剤・注射剤開発、品質管理等を担うグループの製薬機能。

PROCESS DEVELOPMENT

プロセス・製剤開発

新規医薬品候補の特性と開発段階に応じて、製造プロセスおよび製剤化に関する検討を進めます。

QUALITY

品質管理

品質特性、規格、試験、データインテグリティ等を通じて、研究から臨床開発へつながる品質基盤を支えます。詳細は 品質・倫理・ガバナンス に記載しています。


Clinical Development & Clinical Network

Our clinical development support function and our clinical network are linked into a single structure covering study design, clinical trials, monitoring, data management and statistical analysis, through to the accumulation of real-world data.

Findings and new questions from the clinic are brought back into research, informing the next round of scientific validation and development decisions.

CLINICAL DEVELOPMENT & CRO

Medbis Co., Ltd.

Responsible for clinical trials and clinical development, study design, monitoring, data management and statistical analysis. Also responsible for the supply of research materials.

CLINICAL DEVELOPMENT & CRO

メドビス株式会社

臨床試験・臨床開発、試験計画、モニタリング、データマネジメント、統計解析等を担います。また、研究資材の販売・供給を担当します。

Clinical Network

Tokyo

SINCLAIR GINZA CLINIC

Alongside their role in providing care, and with due regard to applicable laws, ethics and the protection of personal information, these institutions support the development of a real-world data foundation that returns clinical data and insight to research and development.


CAPABILITIES

Enquiries about our capabilities

Enquiries about contract work and co-development are received through our partnering contact point.

ウェブサイトご利用条件

Privacy PolicyCookie Policy

サイトマップ

Copyright Advalife Science All Rights Reserved